Article

UC-Davis researcher honored

Susanna Soon-Chun Park, MD, PhD, has received the University of California (UC), Davis, 2011 Joan Oettinger Memorial Award for her research into the use of proton beam irradiation to treat eye conditions.

Sacramento, CA- Susanna Soon-Chun Park, MD, PhD, has received the University of California (UC), Davis, 2011 Joan Oettinger Memorial Award for her research into the use of proton beam irradiation to treat eye conditions.

“I am truly honored and humbled by this honor,” said Dr. Park, a professor of ophthalmology in the UC Davis Health System Eye Center. She said that her research on proton beam irradiation to treat eye disease is part of a collaborative effort among members of the Crocker Nuclear Laboratory at UC Davis, the Department of Radiation Oncology at UC San Francisco, and the UC Davis Health System Eye Center.

UC Davis is one of six institutions nationwide to offer the therapy for ocular melanomas and retinoblastoma. It also has shown potential as an adjunct treatment for exudative macular degeneration.

“Dr. Park’s innovative collaborative research in the application of proton beam technology is only one example of her fine work,” said Mark Mannis, chairman of the department of ophthalmology and director of the eye center. “She is working on what will likely be significant contributions to the application of stem cell technology to diseases of the macula.”

The Oettinger Memorial Award is given annually to recognize outstanding research in cancer and or lung disease. It is named for a UC Davis graduate student who died of lung cancer in 1970. The award recipient receives a stipend of $1,200.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.